Antipsychotic Use in Persons With Dementia

Identifying Attributes

Care Settings
Dementia Care
Country
United States of America
Publishing Organisation
Dementia indicators in Submission Tool and Repository Measure Database
Type of Quality Indicator
Process
IOM Quality Dimension
Safety
Domain
Interventions to Promote Cognition, Independence and Wellbeing

Defining Attributes

Definition

The percentage of individuals 65 years and older with dementia who are receiving an antipsychotic medication without evidence of a psychotic disorder or related condition.

Numerator

The number of individuals from the denominator who had one or more prescription claims and more than 30 days' supply for any antipsychotic medication AND do not have a diagnosis of schizophrenia, bipolar disorder, Huntington's disease or Tourette's Syndrome during the measurement year.

Denominator

Individuals 65 years and older as of the first day of the measurement year, meeting continuous enrolment criteria (the measurement year, with one allowable gap), and with at least one of the following during the measurement year: • Dementia diagnosis • Two or more prescription claims and more than 60 days' supply for a cholinesterase inhibitor or NMDA receptor antagonist.

Exclusions

A diagnosis of schizophrenia, bipolar disorder, Huntington's disease or Tourette's Syndrome during the measurement year

Use of Risk Adjustment
No
Risk Adjustments

None

Stratifications

None

Collection and Reporting Attributes

Type of Data Collection
Administrative data
Data Collection Methods

Claims data

Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No

Source and Reference Attributes

Evidence Source
Technical Specifications
Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
No
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
Yes
Australian Consortium for Aged Care Endorsed
Yes
Identified by PHARMA-Care Project
No
Upload Date
02 December 2025